Clinical Trial Update: SHR Predicts CMD in Patients with CCS

View source ↗

Summary

A completed clinical trial evaluating SHR as a predictor of coronary microvascular dysfunction in patients with chronic coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction
• Coronary Syndrome

Snippet

Sponsor: Ya-Wei Xu | Conditions: Coronary Microvascular Dysfunction (CMD), Index of Microvascular Resistance | Status: COMPLETED